cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pepgen Inc
1 watching
Current Price
$0
$-0.2
(-1.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
407.39M
52-Week High
52-Week High
17.81
52-Week Low
52-Week Low
4.32
Average Volume
Average Volume
0.01M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization407.39M
icon52-Week High17.81
icon52-Week Low4.32
iconAverage Volume0.01M
iconDividend Yield--
iconP/E Ratio--
What does the Pepgen Inc do?
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company s lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Pepgen Inc make?
News & Events about Pepgen Inc.
Globe Newswire
3 months ago
BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur, ...
Globe Newswire
3 months ago
BOSTON, Oct. 13, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, announced the presentation of data ...
Globe Newswire
6 months ago
BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (PepGen), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the ...
Globe Newswire
6 months ago
BOSTON, July 22, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (PepGen), a Boston-based clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the ...
Frequently Asked Questions
Frequently Asked Questions
What is Pepgen Inc share price today?
plus_minus_icon
Can Indians buy Pepgen Inc shares?
plus_minus_icon
How can I buy Pepgen Inc shares from India?
plus_minus_icon
Can Fractional shares of Pepgen Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pepgen Inc stocks?
plus_minus_icon
What is today’s traded volume of Pepgen Inc?
plus_minus_icon
What is today’s market capitalisation of Pepgen Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pepgen Inc?
plus_minus_icon
What percentage is Pepgen Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pepgen Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.2
(-1.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00